MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 216 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $987,564 | +13.6% | 3,525 | +8.3% | 0.01% | +16.7% |
| Q1 2024 | $869,215 | +23.9% | 3,255 | +7.4% | 0.01% | +20.0% |
| Q4 2023 | $701,544 | +67.7% | 3,032 | +5.8% | 0.01% | +25.0% |
| Q3 2023 | $418,405 | -49.2% | 2,865 | -19.7% | 0.00% | -42.9% |
| Q2 2023 | $823,746 | -2.0% | 3,566 | +2.8% | 0.01% | -12.5% |
| Q1 2023 | $840,400 | -14.3% | 3,469 | +2.7% | 0.01% | -11.1% |
| Q4 2022 | $980,465 | +364.7% | 3,378 | +3.8% | 0.01% | +350.0% |
| Q3 2022 | $211,000 | -9.1% | 3,253 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $232,000 | -14.7% | 3,245 | +17.0% | 0.00% | 0.0% |
| Q1 2022 | $272,000 | +19.8% | 2,773 | +3.4% | 0.00% | 0.0% |
| Q4 2021 | $227,000 | +5.1% | 2,681 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $216,000 | -15.3% | 2,711 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $255,000 | -25.4% | 2,614 | -10.7% | 0.00% | -33.3% |
| Q1 2021 | $342,000 | +5.6% | 2,926 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $324,000 | -9.7% | 2,912 | -3.8% | 0.00% | -25.0% |
| Q3 2020 | $359,000 | +40.2% | 3,026 | +33.7% | 0.00% | 0.0% |
| Q2 2020 | $256,000 | – | 2,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |